Updated Oct 9, 2026 · 04:30 UTC
BSXBoston Scientific Corp.
Health Care · United States · XNYS · surgical & medical instruments & apparatus
$41.97+1.11%last session · market closed
Market cap
$60.82b
real-world
Tokenized
$10k
<0.001% of the asset
Avg token price
$42.08
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
BSX · Price
Apr 28, 2025low $41.50 · high $108.35 · now $41.50Oct 8, 2026
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 28
before the open · Sep 2026 quarter · EPS forecast $0.76 (8 analysts)
Last earnings, Jul 29
$0.86 EPS
+3.6% vs $0.83 forecast · Jun 2026 quarter
Real market
Boston Scientific Corp.
Last close
$41.58
Oct 7
Traded on Oct 7
$667.0m
Price now
$41.97
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions
1 token from 1 issuer
wBSXxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
In DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$21.00b
+14% YoY
Operating income
$4.15b
20% margin · +32% YoY
Net income
$3.67b
18% margin · +47% YoY
EPS, diluted
$2.49
+49% YoY
Gross margin
70%
Cash and balance sheet
Free cash flow
$3.63b
17% of revenue
Net debt
$12.09b
$539.0m cash and securities, $12.62b debt
Diluted shares
1.47b
−1% YoY
Valuation at today’s market cap
P/E
17×
EV / sales
3.5×
enterprise value $72.90b
EV / operating income
17.6×
Free cash flow yield
6.0%
Quarterly
RevenueNet income